TRACON Pharmaceuticals, Inc is a biotechnology business based in the US. TRACON Pharmaceuticals shares (TCON) are listed on the NASDAQ and all prices are listed in US Dollars. TRACON Pharmaceuticals employs 18 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in TRACON Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TCON – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
TRACON Pharmaceuticals stock price (NASDAQ: TCON)Use our graph to track the performance of TCON stocks over time.
TRACON Pharmaceuticals shares at a glance
|Latest market close||$6.76|
|52-week range||$1.55 - $12.20|
|50-day moving average||$6.20|
|200-day moving average||$7.97|
|Wall St. target price||$14.57|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.02|
Buy TRACON Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy TRACON Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
TRACON Pharmaceuticals price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-2.59%|
|3 months (2021-04-28)||-11.98%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
TRACON Pharmaceuticals financials
|Gross profit TTM||$-8,198,000|
|Return on assets TTM||-45.61%|
|Return on equity TTM||-153.99%|
|Market capitalisation||$58.9 million|
TTM: trailing 12 months
Shorting TRACON Pharmaceuticals shares
There are currently 701,454 TRACON Pharmaceuticals shares held short by investors – that's known as TRACON Pharmaceuticals's "short interest". This figure is 14.1% up from 614,808 last month.
There are a few different ways that this level of interest in shorting TRACON Pharmaceuticals shares can be evaluated.
TRACON Pharmaceuticals's "short interest ratio" (SIR)
TRACON Pharmaceuticals's "short interest ratio" (SIR) is the quantity of TRACON Pharmaceuticals shares currently shorted divided by the average quantity of TRACON Pharmaceuticals shares traded daily (recently around 169025.06024096). TRACON Pharmaceuticals's SIR currently stands at 4.15. In other words for every 100,000 TRACON Pharmaceuticals shares traded daily on the market, roughly 4150 shares are currently held short.
However TRACON Pharmaceuticals's short interest can also be evaluated against the total number of TRACON Pharmaceuticals shares, or, against the total number of tradable TRACON Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TRACON Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 TRACON Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0699% of the tradable shares (for every 100,000 tradable TRACON Pharmaceuticals shares, roughly 70 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against TRACON Pharmaceuticals.
Find out more about how you can short TRACON Pharmaceuticals stock.
TRACON Pharmaceuticals share dividends
We're not expecting TRACON Pharmaceuticals to pay a dividend over the next 12 months.
Have TRACON Pharmaceuticals's shares ever split?
TRACON Pharmaceuticals's shares were split on a 1:10 basis on 7 November 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TRACON Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for TRACON Pharmaceuticals shares which in turn could have impacted TRACON Pharmaceuticals's share price.
TRACON Pharmaceuticals share price volatility
Over the last 12 months, TRACON Pharmaceuticals's shares have ranged in value from as little as $1.55 up to $12.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TRACON Pharmaceuticals's is 1.9129. This would suggest that TRACON Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TRACON Pharmaceuticals overview
TRACON Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and age-related macular degeneration and fibrotic diseases in the United States. Its lead clinical stage product include envafolimab (KN035), an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma. The company's clinical stage products also include TRC102, which is a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, Phase I clinical trial to treat solid tumors, Phase I to treat solid tumors and lymphomas, and Phase I trial to treat lung cancer; TRC253, a small molecule, which is in Phase II clinical trial for the treatment of metastatic castration-resistant prostate cancer; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. It has collaboration and license agreements with 3D Medicines Co. , Ltd. and Jiangsu Alphamab Biopharmaceuticals Co.
Stocks similar to TRACON Pharmaceuticals
TRACON Pharmaceuticals in the news
TRACON to Report Second Quarter 2021 Financial Results and Company Highlights on August 11, 2021
TRACON to Report Second Quarter 2021 Financial Results and Company Highlights on August 11, 2021
61 Biggest Movers From Yesterday
Frequently asked questionsWhat percentage of TRACON Pharmaceuticals is owned by insiders or institutions?
Currently 1.576% of TRACON Pharmaceuticals shares are held by insiders and 62.965% by institutions. How many people work for TRACON Pharmaceuticals?
Latest data suggests 18 work at TRACON Pharmaceuticals. When does the fiscal year end for TRACON Pharmaceuticals?
TRACON Pharmaceuticals's fiscal year ends in December. Where is TRACON Pharmaceuticals based?
TRACON Pharmaceuticals's address is: 4350 La Jolla Village Drive, San Diego, CA, United States, 92122 What is TRACON Pharmaceuticals's ISIN number?
TRACON Pharmaceuticals's international securities identification number is: US89237H2094 What is TRACON Pharmaceuticals's CUSIP number?
TRACON Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 89237H100
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert